Information on the Results of the Procurement Procedure Conducted under the Request for Proposal RFP - 027916a – PHARMACOKINETIC STUDY OF INVESTIGATIONAL MEDICINAL PRODUCTS FOR ORAL INHALATION 

In connection with the planned implementation of the project entitled “Technological development, clinical demonstration of bioequivalence and implementation of a next-generation triple-combination generic inhaled medicinal product for the maintenance treatment of respiratory diseases: Asthma”, for which Adamed Pharma S.A. (hereinafter: “Adamed”) has been awarded funding from the state budget by the Medical Research Agency under the Competition for the design and development of innovative solutions in the area of new pharmaceutical forms of authorised medicinal products, generic medicinal products and biosimilar medicinal products (Call No. ABM 2026/01), acting pursuant to the Competition Regulations, Adamed hereby informs that, in accordance with the terms of the Request for Proposal, the contract will be awarded to the following Bidder: Pharma Medica Research Inc. 

The selected Bidder met all the conditions for participation in the procurement procedure and submitted the most advantageous offer in terms of price for the contract.